Stefan Siebert

7.9k total citations · 2 hit papers
202 papers, 4.7k citations indexed

About

Stefan Siebert is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Stefan Siebert has authored 202 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Rheumatology, 77 papers in Immunology and 47 papers in Hematology. Recurrent topics in Stefan Siebert's work include Spondyloarthritis Studies and Treatments (94 papers), Rheumatoid Arthritis Research and Therapies (75 papers) and Psoriasis: Treatment and Pathogenesis (69 papers). Stefan Siebert is often cited by papers focused on Spondyloarthritis Studies and Treatments (94 papers), Rheumatoid Arthritis Research and Therapies (75 papers) and Psoriasis: Treatment and Pathogenesis (69 papers). Stefan Siebert collaborates with scholars based in United Kingdom, Canada and United States. Stefan Siebert's co-authors include Iain B. McInnes, G. Fragoulis, Jonathan Cavanagh, Louis Nerurkar, Jamie Robertson, Sinéad Brophy, Roxanne Cooksey, Naveed Sattar, Robert J. B. Nibbs and Lyn D Ferguson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Chemistry.

In The Last Decade

Stefan Siebert

191 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytokines as Therapeutic Targets in Rheumatoid Arthritis and Other Inflammatory Diseases

2015 268 citations Stefan Siebert, Iain B. McInnes et al. profile →
The effect of exercise on cytokines: implications for musculoskeletal health: a narrative review

2022 159 citations Stefan Siebert et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stefan Siebert United Kingdom	35	2.0k	1.4k	822	691	516	202	4.7k
Jeffrey A. Sparks United States	40	2.6k 1.3×	848 0.6×	598 0.7×	738 1.1×	696 1.3×	213	5.3k
Carol Hitchon Canada	38	2.4k 1.2×	923 0.7×	741 0.9×	613 0.9×	579 1.1×	198	5.1k
Karim Raza United Kingdom	49	4.2k 2.2×	2.2k 1.6×	1.4k 1.7×	1.8k 2.6×	595 1.2×	249	9.3k
Clifton O. Bingham United States	60	4.7k 2.4×	1.9k 1.4×	1.6k 1.9×	1.3k 1.8×	912 1.8×	275	11.4k
W. Watson Buchanan United Kingdom	38	2.6k 1.3×	572 0.4×	544 0.7×	467 0.7×	360 0.7×	219	6.3k
Steven Lane United Kingdom	39	428 0.2×	984 0.7×	1.8k 2.2×	2.1k 3.0×	507 1.0×	229	6.1k
Coziana Ciurtin United Kingdom	24	674 0.3×	509 0.4×	197 0.2×	390 0.6×	201 0.4×	154	2.8k
Takuhiro Yamaguchi Japan	42	304 0.2×	578 0.4×	1.3k 1.6×	544 0.8×	781 1.5×	334	7.6k
Sreeram V Ramagopalan United Kingdom	34	662 0.3×	1.2k 0.8×	176 0.2×	715 1.0×	553 1.1×	161	5.5k
Joan M. Bathon United States	61	7.8k 4.0×	2.0k 1.4×	2.8k 3.4×	1.1k 1.6×	784 1.5×	174	12.3k

Countries citing papers authored by Stefan Siebert

Since Specialization

Citations

This map shows the geographic impact of Stefan Siebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Siebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Siebert more than expected).

Fields of papers citing papers by Stefan Siebert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Siebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Siebert. The network helps show where Stefan Siebert may publish in the future.

Co-authorship network of co-authors of Stefan Siebert

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Siebert. A scholar is included among the top collaborators of Stefan Siebert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Siebert. Stefan Siebert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Siebert, Stefan, Laura C. Coates, Georg Schett, et al.. (2024). Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis. Arthritis & Rheumatology. 76(6). 894–904. 4 indexed citations

Steultjens, Martijn, et al.. (2024). Significant functional impairment and disability in individuals with psoriatic arthritis and Achilles tendon pain: a cross-sectional observational study. Rheumatology International. 44(8). 1469–1479. 1 indexed citations

López‐Medina, Clementina, Stefan Siebert, F. Lavie, et al.. (2024). Patient Profiles in Randomized Controlled Trials Versus a Real-World Study in Psoriatic Arthritis: Scoping Review and Metaanalysis. The Journal of Rheumatology. 52(2). jrheum.2024–653.

Poddubnyy, Denis, Dirk Elewaut, Victoria Navarro‐Compán, et al.. (2024). Development of Extramusculoskeletal Manifestations in Upadacitinib‐Treated Patients With Psoriatic Arthritis or Axial Spondyloarthritis. Arthritis & Rheumatology. 77(5). 536–546. 2 indexed citations

Siebert, Stefan, Georg Schett, S. P. Raychaudhuri, et al.. (2023). POS1522 CHANGES IN SERUM CYTOKINES BY WEEK 24 CORRELATE WITH LONG-TERM EFFICACY OF GUSELKUMAB THROUGH 2-YEARS IN BIO-NAÏVE ADULTS WITH PSA. Annals of the Rheumatic Diseases. 82. 1121–1122. 1 indexed citations

Siebert, Stefan, et al.. (2023). Cutaneous lesions in psoriatic arthritis are enriched in chemokine transcriptomic pathways. Arthritis Research & Therapy. 25(1). 73–73. 5 indexed citations

Siebert, Stefan, Kristen Sweet, Christopher T. Ritchlin, et al.. (2023). Guselkumab Modulates Differentially Expressed Genes in Blood of Patients With Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo‐Controlled Trials. ACR Open Rheumatology. 5(9). 490–498. 2 indexed citations

Cole, John, et al.. (2023). Differences in transcriptional changes in psoriasis and psoriatic arthritis skin with immunoglobulin gene enrichment in psoriatic arthritis. Lara D. Veeken. 63(1). 218–225. 3 indexed citations

Kuijk, Arno W. R. van, Michael T. Nurmohamed, Stefan Siebert, et al.. (2023). Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data. Lara D. Veeken. 62(10). 3382–3390. 14 indexed citations

10.

Najm, Aurélie, Carl S. Goodyear, Iain B. McInnes, & Stefan Siebert. (2023). Phenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapy. Nature Reviews Rheumatology. 19(3). 153–165. 17 indexed citations

11.

Gossec, Laure, Elke Theander, Soumya D. Chakravarty, et al.. (2023). Response to treatment in psoriatic arthritis, the effect of age: analysis of patients receiving ustekinumab in the PsABio real-world study. Arthritis Research & Therapy. 25(1). 100–100. 2 indexed citations

12.

Siebert, Stefan, Stephen R. Pennington, S. P. Raychaudhuri, et al.. (2023). Novel Insights From Basic Science in Psoriatic Disease at the GRAPPA 2022 Annual Meeting. The Journal of Rheumatology. 50(Suppl 2). 66–70.

13.

Al‐Mossawi, Hussein, Paul Bowness, Anne Francis, et al.. (2023). Optimising psoriatic arthritis therapy with immunological methods to increase standard evaluation: the protocol of an open-label multicentre, parallel-group, two-arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritis. BMJ Open. 13(9). e078539–e078539. 5 indexed citations

14.

Tucker, Laura, Alexander Allen, David Chandler, et al.. (2022). Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. Lara D. Veeken. 61(9). 3514–3520. 3 indexed citations

15.

Tucker, Laura, Alexander Allen, David Chandler, et al.. (2022). The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. Lara D. Veeken. 61(9). e255–e266. 9 indexed citations

16.

Sweet, Kristen, Qingxuan Song, Matthew J. Loza, et al.. (2021). Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trials. RMD Open. 7(2). e001679–e001679. 32 indexed citations

17.

Siebert, Stefan, Arthur G. Pratt, Claire Wright, et al.. (2021). Impact of the COVID‐19 pandemic on recruitment to clinical research studies in rheumatology. Musculoskeletal Care. 20(1). 209–213. 26 indexed citations

18.

McQueenie, Ross, Bhautesh Jani, Stefan Siebert, et al.. (2021). Prevalence of chronic pain in LTCs and multimorbidity: A cross-sectional study using UK Biobank. SHILAP Revista de lepidopterología. 11. 2572972974–2572972974. 32 indexed citations

19.

Marzo‐Ortega, Helena, Ai Lyn Tan, Dennis McGonagle, et al.. (2020). BSR Spondyloarthritis Course, 27 February 2020. Spondyloarthritis: pathogenesis, diagnosis and management. Rheumatology Advances in Practice. 4(2). rkaa043–rkaa043. 1 indexed citations

20.

Tillett, William, Alexander Allen, Laura Tucker, et al.. (2020). Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope. Lara D. Veeken. 60(4). 1588–1592. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact